RocketTickers

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinep

Long
NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc
AMPH: Amphastar Pharmaceuticals, Inc.
2020-04-27 06:00:10
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

Comments